Amisulpride nolic acid D3 Quebrachitol

Quebrachitol

InChi: InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11

3 μM for KDM4B

Smiles: N#CC1=CC(NC(=O)C(O)=O)=C(Cl)C(=C1)NC(=O)C(O)=O

Amisulpride nolic acid D3 QuebrachitolAmisulpride is an atypical antipsychotic used to treat psychosis in schizophrenia and episodes of mania in bipolar disorder. In Italy, it is also used as a treatment for dysthymia. It was introduced by Sanofi Aventis in the 1990s. Its patent had expired by 2008 and hence generic formulations are now available. Amisulpride function primarily as a D2 and D3 receptor antagonist. It has high affinity for these receptors with dissociation constants of 2. 2